World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as of August 2026.

World Top Biopharmaceutical Companies 2026
World Largest Biopharmaceutical Companies by Market Cap in 2026, World Top Biopharmaceutical Companies by Market Cap in 2026.

  1. AstraZeneca

    World Rank (Aug-2026)
    76
    Market Cap (Aug-2026)
    242.636 Billion USD
    World Rank (Jan-05-2024)
    48
    Market Cap (Jan-05-2024)
    213.330 Billion USD
    World Rank (Jul-30-2023)
    44
    Market Cap (Jul-30-2023)
    221.350 Billion USD
    World Rank (Dec-25-2022)
    40
    Market Cap (Dec-25-2022)
    210.670 Billion USD
    World Rank (Jan-07-2022)
    71
    Market Cap (Jan-07-2022)
    178.12 Billion USD
    Annual Revenue in USD
    45,811 Million USD
    Annual Net Income in USD
    5,955 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    UK
    CEO
    Pascal Soriot
    Stock Category
    FTSE 100
    S&P EUROPE 350
    Yahoo @ NYSE
    Company Profile

    AstraZeneca is UK Based Pharmaceutical and Bio-Technology Company. They have done some advanced research on Oncology. In the fight against COVID-19, AstraZeneca is one among World Top 5 Companies which has done advanced phase of Covid-19 testing in collaboration with the University of Oxford. Headquarters is in UK.

    AstraZeneca Product Sales of 43,789 million USD split by Disease Area for year ending Dec-2023

    Facts About Company

    For year ending Dec-2023, AstraZeneca annual Total revenue was 45,811 million USD and annual operating profit was 8,193 million USD and annual net income was 5,961 million USD.

    AstraZeneca annual revenue was 44,351 million USD for year ending Dec-2022 and annual operating profit was 3,757 million USD and annual net income was 3,293 million USD for year ending Dec-2022.

    AstraZeneca has 89,900 employees as of 2023. 

    Company Website
    Astrazeneca - Healthcare and Pharamaceutical Company
    Wikipedia
    Wikipedia

  2. Amgen

    World Rank (Aug-2026)
    83
    Market Cap (Aug-2026)
    224.092 Billion USD
    World Rank (Jan-05-2024)
    73
    Market Cap (Jan-05-2024)
    162.250 Billion USD
    World Rank (Jul-30-2023)
    105
    Market Cap (Jul-30-2023)
    126.300 Billion USD
    World Rank (Dec-25-2022)
    80
    Market Cap (Dec-25-2022)
    140.820 Billion USD
    World Rank (Jan-07-2022)
    113
    Market Cap (Jan-07-2022)
    128.03 Billion USD
    Annual Revenue in USD
    36,751 Million USD
    Annual Operating Income in USD
    9,080 Million USD
    Annual Net Income in USD
    7,711 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    USA
    CEO
    Robert A. Bradway
    Stock Category
    S&P 500
    Nasdaq 100
    Dow Jones Index (DJIA)
    Yahoo @ Nasdaq
    Company Profile

    Amgen main mission is to serve patients. Amgen is leader in Biotechnology industry, research and making Biotechnology Products. Company has over 25,200 employees as on 2022. Headquarters is in California, USA.

    Amgen Prevents Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations

    Amgen is dedicated to the fight against heart disease and has now launched Breakaway from Heart Disease™. The collective goal of this national campaign is to help make America’s heart health a priority.

    Facts About Company

    As on 2022, Amgen has 25,200 employees.

    Amgen annual revenue generated for period ending Dec-2022 was 26,323 million USD.

    Amgen annual net income generated for period ending Dec-2022 was 6,552 million USD.

    Amgen annual revenue generated for period ending Dec-2021 was 25,979 million USD.

    Split of Annual Revenue by business segment for period ending Dec-2021:

    Company Website
    Amgen Inc - Bio Technology Products Healthcare Company
    Wikipedia
    Wikipedia

  3. Gilead Sciences

    World Rank (Aug-2026)
    127
    Market Cap (Aug-2026)
    171.560 Billion USD
    World Rank (Jan-05-2024)
    133
    Market Cap (Jan-05-2024)
    105.265 Billion USD
    World Rank (Jul-30-2023)
    154
    Market Cap (Jul-30-2023)
    95.871 Billion USD
    World Rank (Dec-25-2022)
    120
    Market Cap (Dec-25-2022)
    106.300 Billion USD
    World Rank (Jan-07-2022)
    180
    Market Cap (Jan-07-2022)
    89.39 Billion USD
    Annual Revenue in USD
    29,443 Million USD
    Annual Operating Income in USD
    10,022 Million USD
    Annual Net Income in USD
    8,510 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    USA
    CEO
    Daniel O'Day
    Stock Category
    S&P 500
    Nasdaq 100
    Yahoo @ Nasdaq
    Company Profile

    GILEAD SCIENCES INC is world’s largest bio-pharmaceutical companies. As on Dec-2021, Gilead Sciences had 14,400 employees across six continents and headquarters is in USA,

    As on 2022, GILEAD SCIENCES INC has 17,000 employees.

    GILEAD SCIENCES INC annual revenue generated for period ending Dec-2022 was 27,281 million USD.

    GILEAD SCIENCES INC annual net loss generated for period ending Dec-2022 was 4,592 million USD.

    Company Website
    Gilead - Biopharmaceutical companies
    Wikipedia
    Wikipedia

  4. Bristol-Myers Squibb Company

    World Rank (Aug-2026)
    177
    Market Cap (Aug-2026)
    130.386 Billion USD
    World Rank (Jan-05-2024)
    130
    Market Cap (Jan-05-2024)
    106.418 Billion USD
    World Rank (Jul-30-2023)
    100
    Market Cap (Jul-30-2023)
    129.010 Billion USD
    World Rank (Dec-25-2022)
    66
    Market Cap (Dec-25-2022)
    154.980 Billion USD
    World Rank (Jan-07-2022)
    96
    Market Cap (Jan-07-2022)
    139.46 Billion USD
    Annual Revenue in USD
    48,194 Million USD
    Annual Operating Income in USD
    10,002 Million USD
    Annual Net Income in USD
    7,055 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    USA
    CEO
    Chris Boerner
    Stock Category
    S&P 500
    Yahoo @ NYSE
    Company Profile

    Bristol-Myers Squibb is USA based healthcare and pharmaceutical multi-national company.

    BMS is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

    Company has over 32,200 employees as on 2021. Headquarters is in USA.

    BMS discover, develop and deliver innovative medicines that help patients prevail over serious diseases

    BMS be the biopharma company that transforms patients' lives through science.

    Facts About Company

    As on 2022, Bristol-Myers Squibb has 34,300 employees.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2022 was 46,159 million USD.

    Bristol-Myers Squibb annual net income generated for period ending Dec-2022 was 6,327 million USD.

    As on 2021, BMS had strong financial results with total revenues growing 9 percent year-over-year to $46.4 billion.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2021 was 46,385 million USD.

    Company Website
    Bristol-Myers Squibb - Pharmaceutical Company
    Wikipedia
    Wikipedia

  5. Vertex Pharmaceuticals

    World Rank (Aug-2026)
    183
    Market Cap (Aug-2026)
    128.188 Billion USD
    World Rank (Jan-05-2024)
    129
    Market Cap (Jan-05-2024)
    107.235 Billion USD
    World Rank (Jul-30-2023)
    161
    Market Cap (Jul-30-2023)
    91.186 Billion USD
    World Rank (Dec-25-2022)
    182
    Market Cap (Dec-25-2022)
    74.361 Billion USD
    World Rank (Jan-07-2022)
    323
    Market Cap (Jan-07-2022)
    56.41 Billion USD
    Annual Revenue in USD
    12,001 Million USD
    Annual Operating Income in USD
    4,173 Million USD
    Annual Net Income in USD
    3,953 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    USA
    CEO
    Reshma Kewalramani
    Stock Category
    S&P 500
    Nasdaq 100
    Yahoo @ Nasdaq
    Company Profile

    VERTEX PHARMACEUTICALS is USA Based Bio-Technology, Bio-Pharmaceutical and Healthcare Company.It have research and development sites, manufacturing facilities and offices around the world. The company locations are North America, Europe, Australia, South America.

    As on 2022, VERTEX PHARMACEUTICALS has 4,500 employees.

    VERTEX PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 8,930 million USD.

    Company Website
    Vertex Pharmaceuticals
    Wikipedia
    Wikipedia

  6. Regeneron Pharmaceuticals

    World Rank (Aug-2026)
    313
    Market Cap (Aug-2026)
    82.722 Billion USD
    World Rank (Jan-05-2024)
    144
    Market Cap (Jan-05-2024)
    100.011 Billion USD
    World Rank (Jul-30-2023)
    174
    Market Cap (Jul-30-2023)
    81.855 Billion USD
    World Rank (Dec-25-2022)
    166
    Market Cap (Dec-25-2022)
    79.143 Billion USD
    World Rank (Jan-07-2022)
    279
    Market Cap (Jan-07-2022)
    64.93 Billion USD
    Annual Revenue in USD
    14,343 Million USD
    Annual Operating Income in USD
    3,578 Million USD
    Annual Net Income in USD
    4,505 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    USA
    CEO
    Leonard Schleifer
    Stock Category
    S&P 500
    Nasdaq 100
    Yahoo @ Nasdaq
    Company Profile

    REGENERON PHARMACEUTICALS is Bio-Pharmaceutical company with headquarters is in New York, USA.

    As on 2022, REGENERON PHARMACEUTICALS has 11,851 employees.

    Facts About Company

    REGENERON PHARMACEUTICALS annual revenue generated for period ending Dec-2022 was 12,172 million USD.

    REGENERON PHARMACEUTICALS annual net income generated for period ending Dec-2022 was 4,338 million USD.

    As on 2022, they had 11,851 employees. They had 7 FDA approved medicines.

    Company Website
    REGENERON PHARMACEUTICALS INC
    Wikipedia
    Wikipedia

  7. Wuxi Apptec

    World Rank (Aug-2026)
    376
    Market Cap (Aug-2026)
    70.431 Billion USD
    World Rank (Jan-05-2024)
    639
    Market Cap (Jan-05-2024)
    28.713 Billion USD
    World Rank (Jul-30-2023)
    657
    Market Cap (Jul-30-2023)
    28.840 Billion USD
    World Rank (Dec-25-2022)
    517
    Market Cap (Dec-25-2022)
    32.132 Billion USD
    World Rank (Jan-07-2022)
    386
    Market Cap (Jan-07-2022)
    50.14 Billion USD
    Annual Revenue in USD
    5,506 Million USD
    Annual Operating Income in USD
    1,364 Million USD
    Annual Net Income in USD
    1,233 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    China
    Yahoo @ HongKong
    Company Profile

    WUXI APPTEC is a pharmaceutical and biotechnology company with headquarters is in China.

    As on 2022, Wuxi AppTec has 29 sites worldwide and more than 44,361 employees globally. Wuxi today provides a broad portfolio of R&D and manufacturing services that support over 4,100 collaborative partners worldwide.

    Company Website
    WuXi AppTec Co., Ltd
    Wikipedia
    Wikipedia

  8. Argenx SE

    World Rank (Aug-2026)
    483
    Market Cap (Aug-2026)
    52.834 Billion USD
    World Rank (Jan-05-2024)
    802
    Market Cap (Jan-05-2024)
    22.967 Billion USD
    World Rank (Jul-30-2023)
    621
    Market Cap (Jul-30-2023)
    30.537 Billion USD
    World Rank (Dec-25-2022)
    799
    Market Cap (Dec-25-2022)
    20.875 Billion USD
    World Rank (Jan-07-2022)
    1,257
    Market Cap (Jan-07-2022)
    16.13 Billion USD
    Annual Revenue in USD
    410 Million USD
    Annual Operating Income in USD
    -719 Million USD
    Annual Net Income in USD
    -709 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Netherlands
    CEO
    Tim Hauwermeiren
    Stock Category
    S&P EUROPE 350
    EURONEXT 100
    EURO STOXX 50
    Yahoo @ Nasdaq
    Company Profile

    Biopharmaceutical company with headquarters is in Netherlands.

    Company Website
    ARGENX SE

  9. Lonza Group

    World Rank (Aug-2026)
    496
    Market Cap (Aug-2026)
    51.870 Billion USD
    World Rank (Jan-05-2024)
    598
    Market Cap (Jan-05-2024)
    30.535 Billion USD
    World Rank (Jul-30-2023)
    414
    Market Cap (Jul-30-2023)
    44.006 Billion USD
    World Rank (Dec-25-2022)
    460
    Market Cap (Dec-25-2022)
    36.081 Billion USD
    World Rank (Jan-07-2022)
    316
    Market Cap (Jan-07-2022)
    57.62 Billion USD
    Annual Revenue in USD
    7,148 Million USD
    Annual Operating Income in USD
    1,559 Million USD
    Annual Net Income in USD
    1,396 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Switzerland
    CEO
    Pierre-Alain Ruffieux
    Stock Category
    S&P EUROPE 350
    Yahoo @ Switzerland
    Company Profile

    Pharmaceutical, Bio Technology and Chemical Company with headquarters is in Basel, Switzerland.

    Company Website
    LONZA GROUP AG
    Wikipedia
    Wikipedia

  10. Samsung Biologics

    World Rank (Aug-2026)
    500
    Market Cap (Aug-2026)
    51.514 Billion USD
    World Rank (Jan-05-2024)
    433
    Market Cap (Jan-05-2024)
    41.719 Billion USD
    World Rank (Jul-30-2023)
    418
    Market Cap (Jul-30-2023)
    43.803 Billion USD
    World Rank (Dec-25-2022)
    354
    Market Cap (Dec-25-2022)
    44.809 Billion USD
    World Rank (Jan-07-2022)
    417
    Market Cap (Jan-07-2022)
    46.57 Billion USD
    Annual Revenue in USD
    2,356 Million USD
    Annual Operating Income in USD
    772 Million USD
    Annual Net Income in USD
    626 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    South Korea
    CEO
    John Rim
    Yahoo @ SouthKorea
    Company Profile

    Samsung Biologics is Biopharmaceutical Manufacturing Company with headquarters is in South Korea. It provides development, manufacturing , laboratory testing services at every stage for Biopharmaceutical products while meeting the evolving needs of the global healthcare industry. The company has 2,587 employees as on 2022.

    Company Website
    Samsung Biolgics
    Wikipedia
    Wikipedia

Share